Notably, MET and EGFR share a downstream signaling pathway, indicating that these receptors collaborate to enhance tumor cell proliferation, movement, invasion, malformation, angiogenesis, metastasis, and resistance to chemotherapy (CT). The gene discussed is MET; the disease is neoplasm.